Maj Invest is one of Denmark's largest independent investment houses, founded in 2005 and based in Copenhagen. The firm manages private equity investments in Danish SMEs as well as minority venture capital and private equity stakes focused on technology, life sciences, and the energy transition.
They made 1 investments in the last 12 months. Their most common stage is series-c (44% of deals). Average disclosed round size is $105.5M (across 6 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series C
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Namdev | Unknown | $37M | Jan 2026 |
| HHemab | Series C | $157M | Oct 2025 |
 FlexiLoans | Series C | — | Jan 2025 |
 Hemab Therapeutics | Series B | $135M | Feb 2023 |
| HHemab Therapeutics Holdings | Series B | $135M | Feb 2023 |
| HHemab Therapeutics Holdings | Series C | $157M | — |
| BBerar Finance Limited | Unknown | — | — |
| SSub-K | Series C | — | — |
| PProtai Bio | Seed | $12M | — |
Top Co-Investors
HealthCap4 shared
Deep Track Capital4 shared
Access Biotechnology4 shared
RA Capital Management4 shared
Rock Springs Capital4 shared
The Invus Group, LLC4 shared
British International Investment2 shared
Sofinnova Partners2 shared
Novo Holdings2 shared
Avon Ventures1 shared
Novo Holdings A/S1 shared
India Quotient1 shared
Nuveen1 shared
Novo Capital1 shared
Franklin Templeton1 shared
FMO1 shared
Pitango HealthTech1 shared
Grove Ventures1 shared
Last updated: 8 September 2026